Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AEGON LTD.AEG · Entity 3394 | Director | September 24, 2026 | September 28, 2026 |
| Lunai Bioworks Inc.RENB · Entity 7981 | Director | October 04, 2023 | October 25, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AEGON LTD.
Report date September 24, 2026 · Filed September 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 4,232 |
Reported balance
After 2026-09-24 transaction · row 1
1 source rowRow 1 · 2026-09-24 · Grant · Acquired 51 · Balance 4,232 F1: Represents an award of dividend equivalent shares associated with the Reporting Person's outstanding equity awards. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of dividend equivalent shares associated with the Reporting Person's outstanding equity awards.
Lunai Bioworks Inc.
Report date October 04, 2023 · Filed October 25, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to purchase shares of common stockSEC Table II · derivative / convertible security · Conversion / exercise price $4.65 · Expires 2033-10-04 | Direct | 16,129 |
Reported balance
After 2023-10-04 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-10-04 · Grant · Acquired 16,129 · Balance 16,129 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 24, 2026 Filed Sep 28, 2026 20:45 UTC | AEGON LTD. AEG · Entity 3394 | GrantCommon Shares | 51 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-044595 · ownership.xml · nonDerivative · entry 1 Boeren Leni · CIK 0001998190 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,232 F1 · kind: Represents an award of dividend equivalent shares associated with the Reporting Person's outstanding equity awards. Read SEC document |
| July 06, 2026 Filed Jul 8, 2026 20:30 UTC | AEGON LTD. AEG · Entity 3394 | GrantCommon Shares | 21 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-032519 · ownership.xml · nonDerivative · entry 1 Boeren Leni · CIK 0001998190 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,181 F1 · kind: Represents an award of dividend equivalent shares associated with the Reporting Person's outstanding equity awards. Read SEC document |
| June 10, 2026 Filed Jun 17, 2026 23:45 UTC | AEGON LTD. AEG · Entity 3394 | GrantCommon Shares | 4,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-029145 · ownership.xml · nonDerivative · entry 1 Boeren Leni · CIK 0001998190 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,160 F1 · kind: Represents a grant of Common Shares subject to time-based vesting in accordance with the applicable grant agreement. Read SEC document |
| October 04, 2023 Filed Oct 25, 2023 14:56 UTC | Lunai Bioworks Inc. RENB · Entity 7981 | GrantOption to purchase shares of common stock · Derivative | 16,129 | $0.00 Strike: $4.65 | $0.00 |
DisclosureSEC source: 0001731122-23-001947 · ownership.xml · derivative · entry 1 Boeren Leni · CIK 0001998190 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,129 Underlying: Common stock · 16,129 shares Expires 2033-10-04 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.